FDA Nanotechnology Task Force Report
In 2006, the U.S. Food and Drug Administration (FDA) initiated the Nanotechnology Task Force to help assess if emerging nanotechnologies pose questions regarding the adequacy and application of the FDA regulatory guidelines. The Task Force'??s initial findings were issued in this report.
|Source:||U.S. Food and Drug Administration|